ReviewJournal of hematology & oncology2023

Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies.

Antonio Tapia-Galisteo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.